Matches in Nanopublications for { ?s ?p "[To test this systematically, we performed small interfering RNA (siRNA) screens in sarcoma cell lines to identify IGF1R pathway components or related protein tyrosine kinase (PTK) networks that modulate the antitumor efficacy of the BMS-536924 IGF1R kinase inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- assertion description "[To test this systematically, we performed small interfering RNA (siRNA) screens in sarcoma cell lines to identify IGF1R pathway components or related protein tyrosine kinase (PTK) networks that modulate the antitumor efficacy of the BMS-536924 IGF1R kinase inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[To test this systematically, we performed small interfering RNA (siRNA) screens in sarcoma cell lines to identify IGF1R pathway components or related protein tyrosine kinase (PTK) networks that modulate the antitumor efficacy of the BMS-536924 IGF1R kinase inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[To test this systematically, we performed small interfering RNA (siRNA) screens in sarcoma cell lines to identify IGF1R pathway components or related protein tyrosine kinase (PTK) networks that modulate the antitumor efficacy of the BMS-536924 IGF1R kinase inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP846870.RAB-qzfR-LpIsEzHNpTKLr1FWGBcCNDeQbnDFsIk2MtXQ130_assertion description "[To test this systematically, we performed small interfering RNA (siRNA) screens in sarcoma cell lines to identify IGF1R pathway components or related protein tyrosine kinase (PTK) networks that modulate the antitumor efficacy of the BMS-536924 IGF1R kinase inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP846870.RAB-qzfR-LpIsEzHNpTKLr1FWGBcCNDeQbnDFsIk2MtXQ130_provenance.
- NP846867.RAaVLFxygsT6wpXQR5oVHufl2zjpvUHG4DFmCd4dGkOfc130_assertion description "[To test this systematically, we performed small interfering RNA (siRNA) screens in sarcoma cell lines to identify IGF1R pathway components or related protein tyrosine kinase (PTK) networks that modulate the antitumor efficacy of the BMS-536924 IGF1R kinase inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP846867.RAaVLFxygsT6wpXQR5oVHufl2zjpvUHG4DFmCd4dGkOfc130_provenance.
- NP376235.RApG7yWqgvvKzoaHe_9Jq-o6vaQ-WBsOO5-H40eZfrjDI130_assertion description "[To test this systematically, we performed small interfering RNA (siRNA) screens in sarcoma cell lines to identify IGF1R pathway components or related protein tyrosine kinase (PTK) networks that modulate the antitumor efficacy of the BMS-536924 IGF1R kinase inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP376235.RApG7yWqgvvKzoaHe_9Jq-o6vaQ-WBsOO5-H40eZfrjDI130_provenance.
- NP394121.RAtxjGMiWiSnSown6jfhJvSoF15kYNvt-jpMgSL87-mZk130_assertion description "[To test this systematically, we performed small interfering RNA (siRNA) screens in sarcoma cell lines to identify IGF1R pathway components or related protein tyrosine kinase (PTK) networks that modulate the antitumor efficacy of the BMS-536924 IGF1R kinase inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP394121.RAtxjGMiWiSnSown6jfhJvSoF15kYNvt-jpMgSL87-mZk130_provenance.
- NP846871.RAjARDYCEFPg-m8IFCQCcWnnVc4lGkOsQpztHUoJV8X3A130_assertion description "[To test this systematically, we performed small interfering RNA (siRNA) screens in sarcoma cell lines to identify IGF1R pathway components or related protein tyrosine kinase (PTK) networks that modulate the antitumor efficacy of the BMS-536924 IGF1R kinase inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP846871.RAjARDYCEFPg-m8IFCQCcWnnVc4lGkOsQpztHUoJV8X3A130_provenance.
- NP402274.RA10rVbuvLx2UQKbjITzSdTEFfoxs4BHVQZWcx2VX92SA130_assertion description "[To test this systematically, we performed small interfering RNA (siRNA) screens in sarcoma cell lines to identify IGF1R pathway components or related protein tyrosine kinase (PTK) networks that modulate the antitumor efficacy of the BMS-536924 IGF1R kinase inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402274.RA10rVbuvLx2UQKbjITzSdTEFfoxs4BHVQZWcx2VX92SA130_provenance.